Image: Garallah, Mohammed A. | Public domain | via Wikimedia Commons
Mustafa Hamied, an 85-year-old Indian businessman, is a key figure in the global pharmaceutical industry. He built his wealth through his involvement with Cipla, a company founded by his father. His career has been marked by a commitment to making healthcare accessible and affordable, especially in developing countries. With a net worth of $1.1 billion, he is ranked among the world's wealthiest individuals.
Mustafa Hamied was born in 1940. His father, Khwaja Abdul Hamied, founded Cipla in 1935. Mustafa inherited the business alongside his brother, Yusuf Hamied, after their father's death.
Mustafa Hamied played a crucial role in the growth and success of Cipla. The company, under his and his brother's leadership, expanded its global presence and diversified its product portfolio. Cipla became known for its efforts to provide affordable medicines, especially for diseases affecting developing countries.
The brothers continued the family's focus on generic pharmaceuticals, developing cost-effective treatments and expanding access to healthcare. His nephew Kamil was appointed to the board in September 2024.
Mustafa Hamied's philanthropy has been channelled through Cipla and other initiatives, with a focus on making healthcare more accessible and affordable in developing countries.
Inherited Cipla with his brother, Yusuf Hamied, after their father's death.
Resigned from the board of Cipla, citing age and health issues.
Supports laboratories and academic institutions to educate individuals about health issues or prevent sickness, primarily impacting people in the developing world.
"I've done more humanitarian work than Bill Gates and Warren Buffett put together."
